These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 10750581)

  • 1. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation.
    Gruver EJ; Fatkin D; Dodds GA; Kisslo J; Maron BJ; Seidman JG; Seidman CE
    Am J Cardiol; 1999 Jun; 83(12A):13H-18H. PubMed ID: 10750581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family.
    Huang X; Song L; Ma AQ; Gao J; Zheng W; Zhou X; Zhang Q; Lu H; Li Y; Liu Y; Hui R
    Clin Chim Acta; 2001 Aug; 310(2):131-9. PubMed ID: 11498078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.
    Posen BM; Moolman JC; Corfield VA; Brink PA
    Br Heart J; 1995 Jul; 74(1):40-6. PubMed ID: 7662452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel missense mutation, Leu390Val, in the cardiac beta-myosin heavy chain associated with pronounced septal hypertrophy in two families with hypertrophic cardiomyopathy.
    Havndrup O; Bundgaard H; Andersen PS; Larsen LA; Vuust J; Kjeldsen K; Christiansen M
    Scand Cardiovasc J; 2000 Dec; 34(6):558-63. PubMed ID: 11214007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children.
    Greber-Platzer S; Marx M; Fleischmann C; Suppan C; Dobner M; Wimmer M
    J Mol Cell Cardiol; 2001 Jan; 33(1):141-8. PubMed ID: 11133230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-->Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure.
    Ko YL; Chen JJ; Tang TK; Cheng JJ; Lin SY; Liou YC; Kuan P; Wu CW; Lien WP; Liew CC
    Hum Genet; 1996 May; 97(5):585-90. PubMed ID: 8655135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis.
    Woo A; Rakowski H; Liew JC; Zhao MS; Liew CC; Parker TG; Zeller M; Wigle ED; Sole MJ
    Heart; 2003 Oct; 89(10):1179-85. PubMed ID: 12975413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy.
    Richard P; Charron P; Leclercq C; Ledeuil C; Carrier L; Dubourg O; Desnos M; Bouhour JB; Schwartz K; Daubert JC; Komajda M; Hainque B
    J Mol Cell Cardiol; 2000 Aug; 32(8):1575-83. PubMed ID: 10900182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
    Epstein ND; Cohn GM; Cyran F; Fananapazir L
    Circulation; 1992 Aug; 86(2):345-52. PubMed ID: 1638703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense mutation of the beta-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy.
    Arai S; Matsuoka R; Hirayama K; Sakurai H; Tamura M; Ozawa T; Kimura M; Imamura S; Furutani Y; Joh-o K
    Am J Med Genet; 1995 Sep; 58(3):267-76. PubMed ID: 8533830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sudden cardiac death in familial hypertrophic cardiomyopathy: are "benign" mutations really benign?
    Semsarian C; Yu B; Ryce C; Lawrence C; Washington H; Trent RJ
    Pathology; 1997 Aug; 29(3):305-8. PubMed ID: 9271024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.
    Perrot A; Schmidt-Traub H; Hoffmann B; Prager M; Bit-Avragim N; Rudenko RI; Usupbaeva DA; Kabaeva Z; Imanov B; Mirrakhimov MM; Dietz R; Wycisk A; Tendera M; Gessner R; Osterziel KJ
    J Mol Med (Berl); 2005 Jun; 83(6):468-77. PubMed ID: 15856146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apical hypertrophic cardiomyopathy due to a de novo mutation Arg719Trp of the beta-myosin heavy chain gene and cardiac arrest in childhood. A case report and family study.
    Döhlemann C; Hebe J; Meitinger T; Vosberg HP
    Z Kardiol; 2000 Jul; 89(7):612-9. PubMed ID: 10957787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
    Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
    Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly.
    Niimura H; Patton KK; McKenna WJ; Soults J; Maron BJ; Seidman JG; Seidman CE
    Circulation; 2002 Jan; 105(4):446-51. PubMed ID: 11815426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counselling issues in familial hypertrophic cardiomyopathy.
    Yu B; French JA; Jeremy RW; French P; McTaggart DR; Nicholson MR; Semsarian C; Richmond DR; Trent RJ
    J Med Genet; 1998 Mar; 35(3):183-8. PubMed ID: 9541100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.
    Tesson F; Richard P; Charron P; Mathieu B; Cruaud C; Carrier L; Dubourg O; Lautié N; Desnos M; Millaire A; Isnard R; Hagege AA; Bouhour JB; Bennaceur M; Hainque B; Guicheney P; Schwartz K; Komajda M
    Hum Mutat; 1998; 12(6):385-92. PubMed ID: 9829907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two murine models of familial hypertrophic cardiomyopathy.
    McConnell BK; Fatkin D; Semsarian C; Jones KA; Georgakopoulos D; Maguire CT; Healey MJ; Mudd JO; Moskowitz IP; Conner DA; Giewat M; Wakimoto H; Berul CI; Schoen FJ; Kass DA; Seidman CE; Seidman JG
    Circ Res; 2001 Mar; 88(4):383-9. PubMed ID: 11230104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.
    Anan R; Greve G; Thierfelder L; Watkins H; McKenna WJ; Solomon S; Vecchio C; Shono H; Nakao S; Tanaka H
    J Clin Invest; 1994 Jan; 93(1):280-5. PubMed ID: 8282798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.